Descripción de la empresa
Fortive Corporation operates as a comprehensive provider of products, software, and services within the scientific and technical instruments industry, serving markets across the United States, China, and internationally through its Intelligent Operating Solutions and Advanced Healthcare Solutions segments. The company is classified within the broader Technology sector, an environment characterized by high innovation cycles and specialized demand for precision instruments that drive industrial efficiency and medical advancements. Currently, the entity demonstrates significant scale with a market capitalization of $17.13 billion and an annual revenue base of $4.16 billion, supported by a workforce of 10,000 employees. These valuation and revenue metrics position Fortive as a substantial mid-to-large-cap player, indicating a level of market penetration and operational reach that allows for diversified exposure across multiple global verticals while maintaining a solid presence in high-growth technological niches.
Salud financiera
The financial performance of Fortive is defined by a trailing twelve-month revenue of $4.16 billion, which generated a net income of $532.70 million and an EBITDA of $1.16 billion, highlighting a substantial difference between top-line sales and bottom-line profit that reflects the company's operational cost structure and tax environment. This gap between revenue and net income underscores the importance of controlling overhead, cost of goods sold, and other operating expenses to maintain profitability in a capital-intensive manufacturing and service delivery model. The company generated free cash flow of $855.86 million, a figure that provides critical financial flexibility for capital allocation, debt servicing, and potential strategic acquisitions without relying solely on external financing. Profitability efficiency is further evidenced by a gross margin of 63.5%, an operating margin of 20.1%, and a profit margin of 13.9%, where the high gross margin suggests strong pricing power or low direct material costs, while the operating and profit margins indicate effective management of broader operational expenses and tax liabilities. Regarding balance sheet strength, Fortive holds cash reserves of $375.50 million against total debt of $3.31 billion, resulting in a debt-to-equity ratio of 51.18, which suggests a leveraged capital structure typical of growth-oriented technology firms rather than a purely conservative approach. Liquidity management is assessed via a current ratio of 0.71, indicating that current assets fall short of covering current liabilities, which points to a reliance on operating cash flow generation rather than liquid asset buffers to meet short-term obligations. Return metrics show a return on equity of 6.4% and a return on assets of 3.1%, figures that reveal the effectiveness of management in deploying shareholder capital and utilizing the asset base to generate returns, with the ROA being relatively modest compared to the ROE, potentially influenced by the company's significant debt load.
Evaluación de valoración
Valuation multiples for Fortive indicate a trailing P/E ratio of 33.91 compared to a forward P/E of 16.93, a significant divergence that implies the market anticipates a substantial improvement in future earnings growth to justify the current high valuation relative to expected performance. The price-to-book ratio stands at 2.62, suggesting that the stock trades at a premium over its book value, which reflects investor confidence in the company's intangible assets, brand strength, and future earnings potential beyond mere tangible net worth. Alternative valuation metrics such as a price-to-sales ratio of 4.12 and an EV/EBITDA of 16.87 provide additional context, indicating that the company is valued heavily on sales growth and earnings power relative to enterprise value, consistent with high-margin technology businesses. Price momentum and range are defined by a 52-week high of $62.42 and a 52-week low of $45.50, meaning the current market price sits somewhere within this band, reflecting recent volatility and market sentiment regarding the stock's fair value. The stock exhibits a beta of 1.00, indicating that its price volatility moves in tandem with the broader market index, offering investors exposure to systemic market risks without significant amplification or dampening relative to the general equity market performance.
Growth & Income
Growth dynamics are characterized by a revenue growth rate of 4.6% year-over-year contrasted with an earnings growth rate of -2.6% year-over-year, revealing that earnings are currently contracting relative to revenue expansion, which may signal margin compression, one-time costs, or a lag in cost management relative to top-line growth. As a dividend payer, Fortive offers a dividend yield of 0.5% with a payout ratio of 17.6%, a conservative payout level that is highly sustainable given the company's earnings profile and leaves ample room for reinvestment or dividend increases if earnings stabilize and grow. The low payout ratio combined with negative earnings growth suggests the company prioritizes operational reinvestment and balance sheet management over aggressive shareholder returns at this specific moment in its growth cycle. Overall, the growth and income profile presents a scenario of moderate revenue expansion that has not yet fully translated into earnings growth, supported by a very sustainable dividend that does not currently constrain the company's ability to fund future initiatives or navigate the cyclical nature of its industrial and healthcare markets.